Abstract
Interpersonal distance regulation is an essential element of social communication. Its impairment in autism spectrum disorder (ASD) is widely acknowledged among practitioners, but only a handful of studies reported empirical research in real-life settings focusing only on children. However, these studies did not measure the alterations of vegetative functions related to interpersonal distance. Here, we introduced a new experimental design to systematically measure interpersonal distance along with heart rate variability (HRV) in adults with ASD and tested the modulatory effect of intentionality, eye-contact, moving activity and attribution. Twenty-two adults diagnosed with ASD and 21 matched neurotypical controls participated in our study from 2019 October to 2020 February. Our new experimental design combined the modified version of the stop distance paradigm with HRV measurement controlling for eye contact between the experimenter and the participant to measure interpersonal distance in incidental and intentional conditions. Our results showed greater preferred distance in ASD in the intentional but not in the incidental condition. These results were altered with eye contact and the participant’s role (active vs. passive) in the stop distance task. Moreover, we found lower baseline HRV and reduced HRV reactivity in ASD; however, these vegetative measurements could not predict preferred interpersonal distance. Our study highlights the importance of interpersonal space regulation in ASD and the need for sophisticated experimental designs to grasp the complexity and underlying factors of distance regulation in typical and atypical populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the National Brain Research Program (project 2017-1.2.1-NKP- 2017-00002, PI: D. N.); the Hungarian Scientific Research Fund (OTKA K 128016, PI: D. N., OTKA PD 124148, PI: K. J.); the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to K. J.); the New National Excellence Program of the Ministry for Innovation and Technology (UNKP-19-2-I-ELTE-332, A. G.); the IDEXLYON Fellowship of the University of Lyon as part of the Programme Investissements d'Avenir (ANR-16-IDEX-0005 to D. N.) and Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the Neurology thematic program of Semmelweis University (to K. F., E. K., B. Sz., J. R.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Regional and Institutional Committee of Science and Research Ethics, Semmelweis University, Budapest, Hungary (SERKEB No.: 145/2019)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵+ Senior Authors
Data Availability
The data that support the findings of this study are available on request from the corresponding author.